Compare Virinchi with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with a -11.08% CAGR growth in Operating Profits over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.30
- The company has been able to generate a Return on Equity (avg) of 2.11% signifying low profitability per unit of shareholders funds
Flat results in Dec 25
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Software Products
INR 188 Cr (Micro Cap)
NA (Loss Making)
21
0.00%
0.63
-2.99%
0.41
Total Returns (Price + Dividend) 
Latest dividend: 0.5 per share ex-dividend date: Sep-17-2012
Risk Adjusted Returns v/s 
Returns Beta
News

Virinchi Ltd Stock Hits 52-Week Low at Rs.16.1 Amidst Continued Underperformance
Virinchi Ltd, a micro-cap player in the Software Products sector, recorded a fresh 52-week low of Rs.16.1 today, marking a significant decline amid persistent challenges in its financial and market performance. Despite a modest rebound after two consecutive days of decline, the stock remains below all key moving averages, reflecting ongoing pressure.
Read full news article
Virinchi Ltd Stock Hits 52-Week Low Amid Continued Downtrend
Shares of Virinchi Ltd, a micro-cap player in the Software Products sector, declined sharply to a fresh 52-week low of Rs 16.33 on 16 Mar 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The stock underperformed its sector by 7.47% on the day, reflecting persistent pressures amid broader market weakness.
Read full news article
Virinchi Ltd Shares Plunge to Lower Circuit Amid Heavy Selling Pressure
Shares of Virinchi Ltd, a micro-cap player in the Software Products sector, plunged sharply on 16 Mar 2026, hitting the lower circuit limit amid intense selling pressure. The stock recorded a maximum daily loss of 8.21%, closing at ₹16.65, marking a fresh 52-week and all-time low. This steep decline reflects mounting investor concerns and panic selling, with volumes surging as supply remained largely unfilled.
Read full news article Announcements 
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
18-Mar-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Viswanath Kompella
Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015
09-Mar-2026 | Source : BSEplease find enclosed
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
26-Feb-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Vivo Bio Tech Ltd
Corporate Actions 
No Upcoming Board Meetings
Virinchi Ltd has declared 5% dividend, ex-date: 17 Sep 12
No Splits history available
Virinchi Ltd has announced 1:1 bonus issue, ex-date: 21 Mar 22
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Feb 2026
Shareholding Compare (%holding) 
Non Institution
17.5803
Held by 0 Schemes
Held by 2 FIIs (0.06%)
Viswanath Kompella (15.03%)
Green Field Meadows Infra Private Limited (2.52%)
49.31%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 24.48% vs -22.54% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 112.21% vs -3,262.79% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -5.53% vs -1.98% in Sep 2024
Growth in half year ended Sep 2025 is -1,082.84% vs -77.63% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -5.94% vs 3.03% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -325.24% vs -55.99% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 0.37% vs -3.82% in Mar 2024
YoY Growth in year ended Mar 2025 is -94.74% vs 6.61% in Mar 2024






